Evolve Medical Education LLC

Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial

Overview / Abstract:	May 2021: VBS Literature Update Heier JS, Brown DM, Shah SP, et al. Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial. JAMA Ophthalmol. 2021 Mar 18:e210221. doi: 10.1001/jamaophthalmol.2021.0221. Epub ahead of print. PMID: 33734306; PMCID: PMC7974836. Abstracted by Brian K. Do, MD
Expiration	Jun 01, 2022
Discipline(s)	Optometry / Ophthalmology CE
Format	Journal, Online
Credits / Hours	0.25
Accreditation	ACCME
Keywords / Search Terms	Evolve Medical Education LLC Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map